Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

A LESS INVASIVE METHOD OF REDUCING THE INCIDENCE OF POST-ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS: INTRAVENOUS DICLOFENAC SODIUM VERSUS PLACEBO

Title: A LESS INVASIVE METHOD OF REDUCING THE INCIDENCE OF POST-ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS: INTRAVENOUS DICLOFENAC SODIUM VERSUS PLACEBO
Authors: Chik, Ian; Jarmin, Razman; Ariffin, Affirul; Othman, Hairol; Zuhdi, Zamri; Azman, Azlanudin; Mahmood, Nik Ritza Kosai Nik
Source: Asian Journal of Pharmaceutical and Clinical Research; Vol 11 Issue 10 October 2018; 140-144 ; 2455-3891 ; 0974-2441
Publisher Information: Innovare Academic Sciences Pvt Ltd
Publication Year: 2018
Collection: Innovare Academic Sciences: E-Journals
Subject Terms: Anti-inflammatory agents; Nonsteroidal; Cholangiopancreatography; Endoscopic retrograde; Pain; Prospective studies; Pharmacology
Description: Objective: The purpose of this study is to reduce the incidence of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) by the administration of intravenous (IV) diclofenac sodium.Methods: This is a prospective, randomized, double-blinded control study. This study was performed in the hepatobiliary unit of general surgery department in University Kebangsaan Malaysia Medical Centre (UKMMC) from May 2015 to May 2016. A total of 128 patients were enrolled in this study. 59 patients were randomized into the treatment arm, while 63 were randomized into the control group. Patients were randomized by envelope system, and patients in the treatment arm received 75 mg of diclofenac sodium intravenously, within 30 min of ERCP commencement. Both groups were observed for PEP post-ERCP and their pain score recorded. Patients' demographic data were also observed.Results: A total of 122 patients were included in the study, with 59 patients randomized into the treatment arm and 63 into the placebo arm. There was an increase of 7.6% PEP rates in the placebo group (12.7% vs. 5.1% in the treatment arm). However, this was not statistically significant (p=0.142)Conclusion: This study shows that IV diclofenac sodium can decrease PEP but is not statistically significant.
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
Relation: https://journals.innovareacademics.in/index.php/ajpcr/article/view/26474/15783; https://journals.innovareacademics.in/index.php/ajpcr/article/view/26474
Availability: https://journals.innovareacademics.in/index.php/ajpcr/article/view/26474
Accession Number: edsbas.2D781299
Database: BASE